These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8465435)

  • 1. Monitoring OKT3 treatment: pharmacodynamic and pharmacokinetic measures.
    Henell KR; Norman DJ
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):83-5. PubMed ID: 8465435
    [No Abstract]   [Full Text] [Related]  

  • 2. OKT3 prophylaxis in kidney transplant recipients: drug monitoring by flow cytometry.
    Cinti P; Cocciolo P; Evangelista B; Orlandini AM; Bruzzone P; Renna Molajoni E; Cortesini R
    Transplant Proc; 1996 Dec; 28(6):3214-6. PubMed ID: 8962245
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo use of OKT3: main issues for the monitoring of treated patients.
    Chatenoud L; Ferran C; Bach JF
    Transplant Proc; 1990 Dec; 22(6):2605-8. PubMed ID: 2124743
    [No Abstract]   [Full Text] [Related]  

  • 4. Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
    Langley J; Dickerman R; Vergne-Marini P; Williams J; Jensik S; Kenyon N; Anderson J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):939-43. PubMed ID: 8442275
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential monitoring of immunoregulatory T cell subsets in renal transplantation.
    Mestre M; González C; Griño JM; Valls A; Bonete J; Mané E; Corominas M; Bas J; Romeu A; Buendia E
    Transplant Proc; 1992 Feb; 24(1):73-5. PubMed ID: 1539351
    [No Abstract]   [Full Text] [Related]  

  • 6. Humoral immune response against OKT3.
    Chatenoud L
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):68-73. PubMed ID: 8465430
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic monitoring after organ transplantation: relationship between Epstein-Barr virus infection and CD19+ B cells measured by flow cytometry.
    Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
    Transplant Proc; 1995 Feb; 27(1):1428-30. PubMed ID: 7533384
    [No Abstract]   [Full Text] [Related]  

  • 8. Presence of different T and B-peripheral blood lymphocyte subsets in liver transplantation after cyclosporine or OKT3 immunosuppressive treatment.
    Minguela A; Alvarez-López MR; Sánchez-Bueno F; Torío A; Muro M; Robles R; Pons JA; Parrilla P; García-Alonso AM
    Transplant Proc; 1995 Aug; 27(4):2317-8. PubMed ID: 7652825
    [No Abstract]   [Full Text] [Related]  

  • 9. CD3 antigen modulation in T-lymphocytes during OKT3 treatment.
    Magnussen K; Klug B; Møller B
    Transplant Proc; 1994 Jun; 26(3):1731. PubMed ID: 8030108
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response to OKT3 and methods for monitoring.
    Schroeder TJ; Hariharan S; First MR
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):77-80. PubMed ID: 8465433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline reduces the first-dose reactions following OKT3.
    Vincenti FG; Vasconcelos M; Birnbaum JL; Tomlanovich SJ; Amend WJ; Melzer JS; Snyder JP
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):57-9. PubMed ID: 8465428
    [No Abstract]   [Full Text] [Related]  

  • 12. Depleting effect of antithymocyte globulin on T-lymphocyte subsets in kidney transplantation.
    Mestre M; Bas J; Alsina J; Grinyó JM; Buendia E
    Transplant Proc; 1999 Sep; 31(6):2254-5. PubMed ID: 10500565
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel and rapid assay to detect anti-idiotypic anti-OKT3 antibodies.
    McIntyre JA; Higgins NG
    Transplantation; 1995 Jun; 59(11):1507-8. PubMed ID: 7778164
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic monitoring during OKT3 therapy.
    Chatenoud L
    Clin Transplant; 1993 Aug; 7(4 Pt 2):422-30. PubMed ID: 10146352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of therapeutic anti-lymphocyte antibodies from human sera prior to anti-human leukocyte antibody testing.
    Bearden CM; Book BK; Sidner RA; Pescovitz MD
    J Immunol Methods; 2005 May; 300(1-2):192-9. PubMed ID: 15896799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro system for evaluation of the immunomodulatory capacity of CD45(R) reagents.
    Poppema S; Visser L; Jiang XY
    Transplant Proc; 1996 Dec; 28(6):3263-4. PubMed ID: 8962266
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological monitoring utilizing novel probes.
    Stewart CC; Stewart SJ
    Ann N Y Acad Sci; 1993 Mar; 677():94-112. PubMed ID: 8494251
    [No Abstract]   [Full Text] [Related]  

  • 18. Allogeneic sensitization alters T-cell reactivity to extracellular matrix proteins in prospective transplant recipients.
    Podobińska I; Stepień-Sopniewska B; Mrowiec T; Korczak-Kowalska G; Wierzbicki P; Lis K; Górski A
    Transplant Proc; 1995 Feb; 27(1):494. PubMed ID: 7879074
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of OKT3 on expression of lymphocyte adhesion molecules in vitro.
    Buysmann S; van Diepen FN; van Kooyk Y; ten Berge RJ
    Transplant Proc; 1994 Dec; 26(6):3249-50. PubMed ID: 7527958
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma.
    Whiteside TL; Zhao Y; Tsukishiro T; Elder EM; Gooding W; Baar J
    Clin Cancer Res; 2003 Feb; 9(2):641-9. PubMed ID: 12576430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.